Fan Ventures
1
38M
1
- Areas of investment
Summary
The standard case for the fund is to invest in rounds with 9 partakers. The meaningful sponsors for the fund in investment in the same round are Uprising, Khosla Ventures, Heritage Provider Network. In the next rounds fund is usually obtained by Wellington Partners, Khosla Ventures, Fresenius Medical Care.
The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars.
We also calculated 1 valuable employee in our database.
Among the most successful fund investment fields, there are Medical, Biotechnology. Among the most popular portfolio startups of the fund, we may highlight eGenesis. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Investments by industry
- Medical (1)
- Biopharma (1)
- Life Science (1)
- Biotechnology (1)
- Genetics (1)
- Investments by region
-
- United States (1)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
EGenesis | 16 Mar 2017 | Biotechnology, Genetics, Medical, Life Science, Biopharma | Early Stage Venture | 38M | United States, Massachusetts, Cambridge |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.